全球獸醫寄生蟲劑市場:按類型(外寄生蟲劑,內殺劑,內殺劑)動物(狗,貓,馬,牛,豬,家禽,山羊)最終用戶(獸醫醫院,動物農場,家庭護理)預測到2027
市場調查報告書
商品編碼
1252920

全球獸醫寄生蟲劑市場:按類型(外寄生蟲劑,內殺劑,內殺劑)動物(狗,貓,馬,牛,豬,家禽,山羊)最終用戶(獸醫醫院,動物農場,家庭護理)預測到2027

Animal Parasiticides Market by Type (Ectoparasiticides, Endoparasiticides, Endectocides), Animal Type (Dogs, Cats, Horses, Cattle, Pigs, Poultry, Goats), End User (Veterinary Hospitals, Animal farms, Home Care Settings) - Global Forecast to 2027

出版日期: | 出版商: MarketsandMarkets | 英文 285 Pages | 訂單完成後即時交付

價格
簡介目錄

預計全球動物殺蟲劑市場規模將從 2022 年的 106 億美元增長到 2027 年的 141 億美元,預測期內復合年增長率為 5.8%。

由於對動物源性食品的需求增加,私營公司增加投資,旨在防止動物疾病傳播的法律以及動物保健成本上升等因素,動物殺寄生蟲劑市場正在增長。我是這裡。 另一方面,關於對食用動物使用殺寄生蟲劑的規定以及向素食主義的轉變預計會阻礙該市場的增長。

“按類型,殺外寄生蟲領域佔比最高”

按類型。 外寄生蟲劑部分將在 2021 年佔據最高份額。 與其他產品相比,外寄生蟲殺滅劑的流行□□,動物擁有量的增加以及新興國家伴侶動物的興起是推動未來市場擴張的一些關鍵因素。

“伴侶動物細分市場將在預測期內佔據最高的市場份額”

按動物類型劃分,伴侶動物將在 2021 年佔據最大份額。 主要原因是飼養寵物的成本不斷上升,發達國家的伴侶動物主人越來越多。

“獸醫醫院和診所部門在預測期內增長最快”

按最終用戶劃分,獸醫醫院和診所部門將在 2021 年增長最快。 在醫療環境中越來越多地使用獸醫殺寄生蟲劑,寄生蟲病的增加以及發展中國家對動物健康的日益關注都促進了該部門的快速增長。

“拉丁美洲在預測期內增長最快”

按地區劃分,預計拉丁美洲在預測期內將快速增長。 伴侶動物和食用動物數量的增加,以及該地區對動物源性食品需求的增長是推動市場增長的主要因素。 特別是,拉丁美洲國家牛肉出口的增加預計將支持該地區動物殺寄生蟲劑市場的擴大。

本報告按物種,動物類型,最終用戶和地區分析了全球獸用殺寄生蟲劑市場,包括市場基本面,當前發展,主要市場驅動因素和製約因素。它研究了不同的市場趨勢前景,市場競爭力狀態,主要參與者的資料等。

內容

第一章介紹

第二章研究方法論

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 介紹
  • 市場動態
    • 司機
    • 約束因素
    • 機會
    • 任務
  • 價格分析
  • 供應鏈分析
  • 生態系統分析
  • 專利分析
  • 價值鏈分析
  • 案例研究
  • 監管分析
  • 波特的五力分析
  • 相鄰市場分析
  • 主要會議和活動 (2023-2024)
  • 主要利益相關者和採購標準
  • 貿易分析
  • 行業趨勢
  • 通貨膨脹和經濟衰退對動物殺寄生蟲劑市場的影響

第 6 章動物殺寄生蟲劑市場:按類型

  • 介紹
  • 殺外寄生蟲劑
    • 澆注劑/點劑
    • 口服片劑
    • 噴霧
    • 浸漬劑
    • 耳標
    • 衣領
    • 其他殺外寄生蟲劑
  • 內部寄生蟲控製劑
    • 口服液
    • 口服固體製劑
    • 注射
    • 飼料添加劑
    • 其他內部寄生蟲控製劑
  • 內殺

第 7 章動物殺寄生蟲劑市場:按動物類型分類

  • 介紹
  • 伴侶動物
    • 其他伴侶動物
  • 牲畜
    • 奶牛
    • 家禽
    • 綿羊和山羊
    • 其他牲畜

第 8 章動物殺寄生蟲劑市場:按最終用戶分類

  • 介紹
  • 獸醫醫院和診所
  • 動物農場
  • 家庭護理

第 9 章動物殺寄生蟲劑市場:按地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 澳大利亞和新西蘭
    • 日本
    • 印度
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 土耳其人
    • 其他中東和非洲國家

第10章競爭格局

  • 概覽
  • 主要公司的戰略
  • 動物殺寄生蟲劑市場:主要參與者的收入份額分析
  • 市場份額分析
  • 主要公司的研發 (R&D) 評估
  • 公司評估象限
  • 競爭領導力映射:適用於中小型企業和初創企業
  • 競爭基準
  • 競爭場景
    • 產品發布和批准
    • 資本交易
    • 其他趨勢

第11章公司簡介

  • 主要公司
    • BOEHRINGER INGELHEIM GMBH
    • ZOETIS INC.
    • ELANCO ANIMAL HEALTH INCORPORATED
    • MERCK & CO., INC
    • VIRBAC
    • VETOQUINOL S.A.
    • PETIQ, LLC
    • SEQUENT SCIENTIFIC LIMITED
    • KRKA GROUP
    • ECO ANIMAL HEALTH GROUP PLC
  • 其他企業
    • CEVA SANTE ANIMALE
    • CHANELLE PHARMA
    • BIMEDA ANIMAL HEALTH
    • NORBROOK
    • KYORITSU SEIYAKU CORPORATION
    • SMARTVET HOLDINGS, INC.
    • UCBVET
    • CALIER
    • ABBEY ANIMAL HEALTH PTY LTD.
    • BIOGENESIS BAGO
    • PRN PHARMACAL
    • LUTIM PHARMA PRIVATE LIMITED
    • VETANCO SA
    • BRILLIANT BIO PHARMA
    • ZUCHE PHARMACEUTICALS PVT. LTD.

第12章 附錄

簡介目錄
Product Code: PH 2460

The market for animal parasiticides is anticipated to grow from USD 10.6 billion in 2022 to USD 14.1 billion in 2027, at a CAGR of 5.8% over the forecast period. The market for animal parasiticides is expanding as a result of factors like the rising demand for food products made from animals, growing private player investments, laws aimed at preventing the spread of animal diseases, and rising costs for animal health care. During the projected period, regulations on the use of parasiticides on animals used for food production and a move toward vegetarianism will likely hamper the growth of this market.

"ectoparasiticides segment was dominated by the highest share in animal parasiticides market"

The animal parasiticides market is divided into endoparasiticides, ectoparasiticides, and endectocides based on type. The ectoparasiticides segment accounted for the highest share of the global animal parasiticides market in 2021. The high adoption of ectoparasiticides relative to other products is responsible for the huge proportion of this market. The rise in ownership of animals and the number of companion animals in developed nations are additional factors that are anticipated to promote market expansion throughout the projected period.

"Companion animals segment is accounted for highest market share in the forecast period."

The market for animal parasiticides is divided into divisions for companion animals and livestock animals based on the animal type. The companion animals was the largest segment of the global market for animal parasiticides in 2021. Companion animals accounted for the largest share of the global animal parasiticides market in 2021. The significant market share of this sector is largely due to the rising costs of keeping pets and the rise in the number of people who own companion animals in developed countries.

"Veterinary clinics & hospitals segment is expected to witness the fastest growth in the forecast period."

Animal farms, veterinary clinics & hospitals, and home care settings comprise the end-user segments of the market for animal parasiticides. The fastest growing market for animal parasiticides in 2021 was held by veterinary clinics and hospitals. The increased use of animal parasiticides in medical settings, the rise in parasitic illnesses, and the rising concern over animal health in developing nations are all factors that contribute to the fastest growth of this segment.

"Latin America is expected to witness the fastest growth in the forecast period."

In the forecast period, Latin America in the animal parasiticides market will have the fastest rising regional growth. Rising numbers of companion and food-producing animals, as well as the region's rising demand for food items generated from animals, are the main factors driving market growth. Several countries in Latin America are significant suppliers of beef to the global market. China has been recognized as the primary market for Brazilian beef exports, despite an increase in volume and overall value over the previous year. In the upcoming years, it is anticipated that a rise in beef exports from Latin American nations would support a rise in the market for animal parasiticides in this area.

Following is a list of the major players (supply-side) in the animal parasiticides market that this study refers to:

By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20%

By Designation: C-level- 35%, Director Level-25%, and Others- 40%

By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle

East and Africa-2%

Several of the major companies in the market for animal parasiticides include Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (Ireland).

Research Coverage:

The market study analyzes the main market segments for animal parasiticides. The objective of this study is to estimate the market's size and growth potential across several categories according to kind, animal type, end user, and region. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.

Key Benefits of Buying the Report:

The study provides data regarding the animal parasiticides market's closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market's pulse and learning about its major drivers, inhibitors, opportunities, and problems.

The report provides insights on the following pointers:

Analysis of key drivers (Rising demand for animal-derived food products, Growing prevalence of animal diseases, Regulations for preventing spread of animal diseases), restraints (Regulations restricting use of parasiticides for food-producing animals), opportunities (Lucrative growth opportunities in emerging markets), and challenges (Stringent regulatory approval process for drugs) influencing the growth of the Animal parasiticide market.

Product Development/innovation:

Comprehensive details on new technologies, R&D initiatives, and product and service launches for animal parasiticides market

Market Development:

Comprehensive data on attractive markets, and the research analyzes the global animal parasiticides market.

Market Diversification:

Detailed information on emerging products and services, unexplored regions, current trends, and investments in the animal parasiticide market.

Competitive Assessment:

Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the animal parasiticide market like Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (Ireland).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 ANIMAL PARASITICIDES MARKET SEGMENTATION
    • FIGURE 2 ANIMAL PARASITICIDES MARKET, BY REGION
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
    • 1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 3 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 4 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS INC.
    • FIGURE 10 SUPPLY-SIDE ANALYSIS: ANIMAL PARASITICIDES MARKET (2021)
    • FIGURE 11 COUNTRY-LEVEL ANALYSIS OF ANIMAL PARASITICIDES MARKET
    • FIGURE 12 BOTTOM-UP APPROACH
    • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ANIMAL PARASITICIDES MARKET (2022-2027): IMPACT ON MARKET GROWTH AND CAGR
    • FIGURE 14 CAGR PROJECTIONS
    • FIGURE 15 TOP-DOWN APPROACH
  • 2.3 LIMITATIONS
    • 2.3.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.3.2 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS
  • 2.6 RISK ASSESSMENT/LIMITATIONS
  • 2.7 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY

    • FIGURE 17 ANIMAL PARASITICIDES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 18 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 19 ANIMAL PARASITICIDES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 20 GEOGRAPHICAL SNAPSHOT OF ANIMAL PARASITICIDES MARKET

4 PREMIUM INSIGHTS

  • 4.1 ANIMAL PARASITICIDES MARKET OVERVIEW
    • FIGURE 21 GROWING PREVALENCE OF ANIMAL DISEASES AND RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
  • 4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE AND COUNTRY (2021)
    • FIGURE 22 ECTOPARASITICIDES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ANIMAL PARASITICIDES MARKET IN 2021
  • 4.3 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 ANIMAL PARASITICIDES MARKET: REGIONAL MIX
    • FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE ANIMAL PARASITICIDES MARKET IN 2027
  • 4.5 ANIMAL PARASITICIDES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
    • FIGURE 25 DEVELOPING COUNTRIES TO OFFER GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 26 ANIMAL PARASITICIDES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising demand for animal-derived food products
    • FIGURE 27 WORLD MILK PRODUCTION ESTIMATES (2021-2030)
    • FIGURE 28 WORLD MEAT PRODUCTION ESTIMATES (2021-2030)
      • 5.2.1.2 Increasing investments by private players
      • 5.2.1.3 Growing concerns of zoonotic diseases
      • 5.2.1.4 Regulations for preventing spread of animal diseases
      • 5.2.1.5 Growing companion animal ownership rates
    • FIGURE 29 EUROPE: PET POPULATION
      • 5.2.1.6 Growing prevalence of animal diseases
      • 5.2.1.7 Rising animal health expenditure
    • FIGURE 30 US: INCREASING PET EXPENDITURE, 2010-2021 (USD BILLION)
    • FIGURE 31 EUROPE: ANNUAL VALUE OF PET-RELATED PRODUCTS, 2010-2021 (EUR BILLION)
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Regulations restricting use of parasiticides for food-producing animals
      • 5.2.2.2 Shift toward vegetarianism
      • 5.2.2.3 Novel drug development models
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Lucrative growth opportunities in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Growing resistance to parasiticides
    • TABLE 1 PARASITICIDES AND RESISTANT PARASITES
      • 5.2.4.2 Stringent regulatory approval process for drugs
      • 5.2.4.3 Diversity in parasite species
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE OF ANIMAL PARASITICIDES, BY TYPE
    • TABLE 2 AVERAGE SELLING PRICE OF ANIMAL PARASITICIDES, BY TYPE (USD)
    • 5.3.2 AVERAGE SELLING PRICE TRENDS
  • 5.4 SUPPLY CHAIN ANALYSIS
    • FIGURE 32 SUPPLY CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 33 ECOSYSTEM ANALYSIS: ANIMAL PARASITICIDES MARKET
  • 5.6 PATENT ANALYSIS
    • FIGURE 34 PATENT PUBLICATION TRENDS (JANUARY 2013-FEBRUARY 2023)
    • 5.6.1 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR ANIMAL PARASITICIDES
    • FIGURE 35 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR ANIMAL PARASITICIDE PATENTS (2013-2023)
  • 5.7 VALUE CHAIN ANALYSIS
    • FIGURE 36 VALUE CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET
  • 5.8 CASE STUDIES
    • FIGURE 37 CASE STUDY: MARKET ASSESSMENT FOR COMPANION ANIMALS
    • FIGURE 38 CASE STUDY: OPPORTUNITY ANALYSIS FOR BROAD-SPECTRUM PARASITICIDES
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 REGULATORY LANDSCAPE
    • TABLE 3 US: RECENT DEVELOPMENTS IN REGULATIONS FOR VETERINARY DRUGS
    • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.9.2.1 North America
    • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.9.2.2 Europe
    • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.9.2.3 Asia Pacific and Rest of the World
    • TABLE 6 ASIA PACIFIC AND REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 PORTER'S FIVE FORCES ANALYSIS: ANIMAL PARASITICIDES MARKET (2021)
    • 5.10.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.10.2 BARGAINING POWER OF SUPPLIERS
    • 5.10.3 BARGAINING POWER OF BUYERS
    • 5.10.4 THREAT OF NEW ENTRANTS
    • 5.10.5 THREAT OF SUBSTITUTES
  • 5.11 ADJACENT MARKET ANALYSIS
    • FIGURE 39 ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET: MARKET OVERVIEW
  • 5.12 KEY CONFERENCES AND EVENTS DURING 2023-2024
    • TABLE 8 ANIMAL PARASITICIDES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF ANIMAL PARASITICIDES
    • TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF ANIMAL PARASITICIDES
    • 5.13.2 BUYING CRITERIA
    • TABLE 10 KEY BUYING CRITERIA FOR TOP THREE TYPES OF ANIMAL PARASITICIDES
  • 5.14 TRADE ANALYSIS
  • 5.15 INDUSTRY TRENDS
    • 5.15.1 GROWING CONSOLIDATION IN ANIMAL HEALTH INDUSTRY
    • TABLE 11 MAJOR ACQUISITIONS IN ANIMAL PARASITICIDES INDUSTRY (2019-2021)
    • 5.15.2 INNOVATIONS IN ANIMAL PARASITICIDES
    • TABLE 12 INNOVATIVE ANIMAL PHARMACEUTICAL TRENDS
  • 5.16 IMPACT OF INFLATION AND RECESSION ON ANIMAL PARASITICIDES MARKET

6 ANIMAL PARASITICIDES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 13 ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 14 ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.2 ECTOPARASITICIDES
    • TABLE 15 EXAMPLES OF ECTOPARASITICIDES AVAILABLE IN MARKET
    • TABLE 16 ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 17 ECTOPARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.1 POUR-ONS & SPOT-ONS
      • 6.2.1.1 Ease of application to support adoption
    • TABLE 18 POUR-ONS & SPOT-ONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.2 ORAL TABLETS
      • 6.2.2.1 High medication compliance and ease of administration to drive market
    • TABLE 19 ORAL TABLETS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.3 SPRAYS
      • 6.2.3.1 Low price and convenience to drive market
    • TABLE 20 SPRAYS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.4 DIPS
      • 6.2.4.1 High popularity ensured sustained end-user demand
    • TABLE 21 DIPS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.5 EAR TAGS
      • 6.2.5.1 Highly effective in controlling flies around cattle
    • TABLE 22 EAR TAGS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.6 COLLARS
      • 6.2.6.1 Growing prevalence of infections in companion animals to drive adoption
    • TABLE 23 COLLARS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.7 OTHER ECTOPARASITICIDES
    • TABLE 24 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.3 ENDOPARASITICIDES
    • TABLE 25 EXAMPLES OF ENDOPARASITICIDES AVAILABLE IN MARKET
    • TABLE 26 ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 27 ENDOPARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.1 ORAL LIQUIDS
      • 6.3.1.1 Growing demand for meat and milk products to drive market
    • TABLE 28 ORAL LIQUIDS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.2 ORAL SOLIDS
      • 6.3.2.1 Emergence of internal parasitic infections in dogs to drive market
    • TABLE 29 ORAL SOLIDS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.3 INJECTABLES
      • 6.3.3.1 Mostly used in food-producing animals
    • TABLE 30 INJECTABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.4 FEED ADDITIVES
      • 6.3.4.1 Can be administered to large number of animals at once
    • TABLE 31 FEED ADDITIVES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.5 OTHER ENDOPARASITICIDES
    • TABLE 32 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.4 ENDECTOCIDES
    • 6.4.1 POTENTIAL TO TREAT BOTH INTERNAL AND EXTERNAL PARASITE INFECTIONS
    • TABLE 33 EXAMPLES OF ENDECTOCIDES AVAILABLE IN MARKET
    • TABLE 34 ENDECTOCIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

7 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE

  • 7.1 INTRODUCTION
    • TABLE 35 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
  • 7.2 COMPANION ANIMALS
    • TABLE 36 COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 37 COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.1 DOGS
      • 7.2.1.1 Most adopted companion animals
    • TABLE 38 COMPANION ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.2 CATS
      • 7.2.2.1 High vulnerability to parasitic infections to support market growth
    • TABLE 39 COMPANION ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.3 HORSES
      • 7.2.3.1 Rising need for equine parasitic control to drive market
    • TABLE 40 HORSE POPULATION, BY REGION, 2016-2019 (MILLION)
    • TABLE 41 COMPANION ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.4 OTHER COMPANION ANIMALS
    • TABLE 42 OTHER COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 LIVESTOCK
    • FIGURE 41 PRODUCTION OF MEAT WORLDWIDE, BY TYPE, 2016-2020
    • TABLE 43 LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 44 LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.1 CATTLE
      • 7.3.1.1 Susceptible to parasitic infestations and diseases due to internal parasites
    • TABLE 45 LIVESTOCK PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.2 PIGS
      • 7.3.2.1 Growing pork consumption to drive demand for parasiticides
    • TABLE 46 LIVESTOCK PARASITICIDES MARKET FOR PIGS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.3 POULTRY
      • 7.3.3.1 Growing egg consumption in emerging countries to drive demand for parasiticides
    • FIGURE 42 LEADING EGG-PRODUCING COUNTRIES WORLDWIDE, 2019
    • TABLE 47 LIVESTOCK PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.4 SHEEP & GOATS
      • 7.3.4.1 Growth in consumption of sheep and goat meat to drive market
    • TABLE 48 LIVESTOCK PARASITICIDES MARKET FOR SHEEP & GOATS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.5 OTHER LIVESTOCK
    • TABLE 49 OTHER LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 ANIMAL PARASITICIDES MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 50 ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.2 VETERINARY HOSPITALS AND CLINICS
    • 8.2.1 HIGH ADOPTION OF ANIMAL PARASITICIDES IN VETERINARY HOSPITALS AND CLINICS TO DRIVE MARKET
    • TABLE 51 ANIMAL PARASITICIDES MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 ANIMAL FARMS
    • 8.3.1 INCREASING INCIDENCE OF PARASITIC INFECTIONS IN LIVESTOCK TO SUPPORT MARKET GROWTH
    • TABLE 52 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 HOME CARE SETTINGS
    • 8.4.1 RISING PET OWNERSHIP AND AWARENESS TO DRIVE MARKET
    • TABLE 53 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020-2027 (USD MILLION)

9 ANIMAL PARASITICIDES MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 43 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 54 ANIMAL PARASITICIDES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 44 NORTH AMERICA: ANIMAL PARASITICIDES MARKET SNAPSHOT
    • 9.2.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN NORTH AMERICA
    • TABLE 55 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 56 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 57 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 58 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 59 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 60 NORTH AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 61 NORTH AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 62 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 Rising pet expenditure and increasing meat consumption to drive market
    • FIGURE 45 US: PET ADOPTION DURING COVID-19 PANDEMIC
    • FIGURE 46 US: INCREASE IN PET EXPENDITURE, 2011-2021 (USD BILLION)
    • FIGURE 47 US: BEEF CONSUMPTION, 2011-2021 (BILLION POUNDS)
    • TABLE 63 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2018 VS. 2019 VS. 2020
    • TABLE 64 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 65 US: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 66 US: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 67 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 68 US: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 69 US: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 70 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Growing pet adoption to support market growth
    • TABLE 71 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 72 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 73 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 74 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 75 CANADA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 76 CANADA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 77 CANADA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 78 EUROPE: LIVESTOCK POPULATION, BY TYPE, 2011-2021 (MILLION)
    • 9.3.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN EUROPE
    • TABLE 79 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 80 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 82 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 83 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 84 EUROPE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 85 EUROPE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Growing demand for quality animal-derived food products to drive market
    • TABLE 87 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 88 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 89 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 90 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 91 GERMANY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 92 GERMANY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Increasing pet ownership to drive market
    • TABLE 94 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 95 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 96 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 98 UK: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 UK: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 100 UK: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.4 FRANCE
      • 9.3.4.1 Presence of major market players to propel market growth
    • TABLE 101 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 102 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 105 FRANCE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 106 FRANCE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 107 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing animal health expenditure to drive market
    • TABLE 108 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 109 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 110 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 112 SPAIN: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 SPAIN: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 114 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.6 ITALY
      • 9.3.6.1 Need to curb zoonotic diseases in livestock to propel market
    • TABLE 115 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 116 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 117 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 119 ITALY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 ITALY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 121 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • FIGURE 48 NETHERLANDS: NUMBER OF DAIRY COWS, 2011-2020 (THOUSAND)
    • TABLE 122 REST OF EUROPE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2021 (MILLION)
    • TABLE 123 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 124 REST OF EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 125 REST OF EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 127 REST OF EUROPE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 128 REST OF EUROPE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 129 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 49 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET SNAPSHOT
    • 9.4.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN ASIA PACIFIC
    • TABLE 130 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 131 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Increasing pet expenditure and companion animal ownership to propel market
    • FIGURE 50 CHINA: CONSUMPTION OF PORK PRODUCTS PER CAPITA, 2011-2021 (KILOGRAMS)
    • TABLE 138 CHINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 139 CHINA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 140 CHINA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 141 CHINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 142 CHINA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 143 CHINA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 144 CHINA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.3 AUSTRALIA & NEW ZEALAND
      • 9.4.3.1 Rising livestock population and increasing awareness about parasitic infections to drive market
    • TABLE 145 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 AUSTRALIA & NEW ZEALAND: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 147 AUSTRALIA & NEW ZEALAND: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 148 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 149 AUSTRALIA & NEW ZEALAND: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 150 AUSTRALIA & NEW ZEALAND: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 151 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.4 JAPAN
      • 9.4.4.1 Rising pet care expenditure to propel market
    • TABLE 152 JAPAN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 JAPAN: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 154 JAPAN: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 155 JAPAN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 156 JAPAN: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 157 JAPAN: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 158 JAPAN: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.5 INDIA
      • 9.4.5.1 Rising demand for animal-derived food products to support market growth
    • TABLE 159 INDIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 160 INDIA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 161 INDIA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 162 INDIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 163 INDIA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 164 INDIA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 165 INDIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Rising investments in animal healthcare infrastructure to propel market
    • TABLE 166 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 167 SOUTH KOREA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 168 SOUTH KOREA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 169 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 170 SOUTH KOREA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 SOUTH KOREA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.7 REST OF ASIA PACIFIC
    • TABLE 173 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 174 REST OF ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 175 REST OF ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 176 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 177 REST OF ASIA PACIFIC: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 178 REST OF ASIA PACIFIC: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN LATIN AMERICA
    • TABLE 180 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 181 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 182 LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 183 LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 184 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 185 LATIN AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 186 LATIN AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 187 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.5.2 BRAZIL
      • 9.5.2.1 Growing prevalence of zoonotic diseases to drive market
    • TABLE 188 BRAZIL: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 189 BRAZIL: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 190 BRAZIL: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 191 BRAZIL: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 192 BRAZIL: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 193 BRAZIL: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 194 BRAZIL: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.5.3 REST OF LATIN AMERICA
    • TABLE 195 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 196 REST OF LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 197 REST OF LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 198 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 199 REST OF LATIN AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 200 REST OF LATIN AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 201 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN MIDDLE EAST AND AFRICA
    • TABLE 202 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 203 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 204 MIDDLE EAST AND AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 205 MIDDLE EAST AND AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 206 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 207 MIDDLE EAST AND AFRICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 208 MIDDLE EAST AND AFRICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 209 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.6.2 TURKEY
      • 9.6.2.1 Increase in companion animal population to drive market
    • TABLE 210 TURKEY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 211 TURKEY: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 212 TURKEY: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 213 TURKEY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 214 TURKEY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 215 TURKEY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 216 TURKEY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.6.3 REST OF MIDDLE EAST AND AFRICA
    • TABLE 217 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 218 REST OF MIDDLE EAST AND AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 219 REST OF MIDDLE EAST AND AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 220 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 221 REST OF MIDDLE EAST AND AFRICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 222 REST OF MIDDLE EAST AND AFRICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 223 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES
    • FIGURE 51 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN ANIMAL PARASITICIDES MARKET
  • 10.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN ANIMAL PARASITICIDES MARKET
    • FIGURE 52 REVENUE ANALYSIS FOR KEY PLAYERS IN ANIMAL PARASITICIDES MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 53 ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
    • TABLE 224 ANIMAL PARASITICIDES MARKET: DEGREE OF COMPETITION
  • 10.5 R&D ASSESSMENT OF KEY PLAYERS
  • 10.6 COMPANY EVALUATION QUADRANT
    • FIGURE 54 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX, 2021
    • 10.6.1 STARS
    • 10.6.2 PERVASIVE PLAYERS
    • 10.6.3 EMERGING LEADERS
    • 10.6.4 PARTICIPANTS
  • 10.7 COMPETITIVE LEADERSHIP MAPPING FOR SMES AND STARTUPS
    • FIGURE 55 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX FOR SMES AND STARTUPS, 2021
    • 10.7.1 PROGRESSIVE COMPANIES
    • 10.7.2 DYNAMIC COMPANIES
    • 10.7.3 STARTING BLOCKS
    • 10.7.4 RESPONSIVE COMPANIES
  • 10.8 COMPETITIVE BENCHMARKING
    • 10.8.1 OVERALL COMPANY FOOTPRINT
    • TABLE 225 OVERALL COMPANY FOOTPRINT
    • TABLE 226 COMPANY FOOTPRINT ANALYSIS, BY TYPE
    • TABLE 227 COMPANY FOOTPRINT ANALYSIS, BY ANIMAL TYPE
    • TABLE 228 COMPANY FOOTPRINT ANALYSIS, BY END USER
    • TABLE 229 COMPANY FOOTPRINT ANALYSIS, BY REGION
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
    • TABLE 230 PRODUCT LAUNCHES AND APPROVALS, JANUARY 2019-FEBRUARY 2023
    • 10.9.2 DEALS
    • TABLE 231 DEALS, JANUARY 2019-FEBRUARY 2023
    • 10.9.3 OTHER DEVELOPMENTS
    • TABLE 232 OTHER DEVELOPMENTS, JANUARY 2019-FEBRUARY 2023

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

    • 11.1.1 BOEHRINGER INGELHEIM GMBH
    • TABLE 233 BOEHRINGER INGELHEIM GMBH: BUSINESS OVERVIEW
    • FIGURE 56 BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT (2021)
    • 11.1.2 ZOETIS INC.
    • TABLE 234 ZOETIS INC.: BUSINESS OVERVIEW
    • FIGURE 57 ZOETIS INC.: COMPANY SNAPSHOT (2021)
    • 11.1.3 ELANCO ANIMAL HEALTH INCORPORATED
    • TABLE 235 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 58 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2021)
    • 11.1.4 MERCK & CO., INC
    • TABLE 236 MERCK & CO., INC.: BUSINESS OVERVIEW
    • FIGURE 59 MERCK & CO., INC.: COMPANY SNAPSHOT (2021)
    • 11.1.5 VIRBAC
    • TABLE 237 VIRBAC: BUSINESS OVERVIEW
    • FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2021)
    • 11.1.6 VETOQUINOL S.A.
    • TABLE 238 VETOQUINOL S.A.: BUSINESS OVERVIEW
    • FIGURE 61 VETOQUINOL S.A.: COMPANY SNAPSHOT (2021)
    • 11.1.7 PETIQ, LLC
    • TABLE 239 PETIQ, LLC: BUSINESS OVERVIEW
    • FIGURE 62 PETIQ, LLC: COMPANY SNAPSHOT (2021)
    • 11.1.8 SEQUENT SCIENTIFIC LIMITED
    • TABLE 240 SEQUENT SCIENTIFIC LIMITED: BUSINESS OVERVIEW
    • FIGURE 63 SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT (2021)
    • 11.1.9 KRKA GROUP
    • TABLE 241 KRKA GROUP: BUSINESS OVERVIEW
    • FIGURE 64 KRKA GROUP: COMPANY SNAPSHOT (2021)
    • 11.1.10 ECO ANIMAL HEALTH GROUP PLC
    • TABLE 242 ECO ANIMAL HEALTH GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 65 ECO ANIMAL HEALTH GROUP PLC: COMPANY SNAPSHOT (2021)
  • 11.2 OTHER PLAYERS
    • 11.2.1 CEVA SANTE ANIMALE
    • TABLE 243 CEVA SANTE ANIMALE: BUSINESS OVERVIEW
    • 11.2.2 CHANELLE PHARMA
    • TABLE 244 CHANELLE PHARMA: BUSINESS OVERVIEW
    • 11.2.3 BIMEDA ANIMAL HEALTH
    • TABLE 245 BIMEDA ANIMAL HEALTH: BUSINESS OVERVIEW
    • 11.2.4 NORBROOK
    • TABLE 246 NORBROOK: BUSINESS OVERVIEW
    • 11.2.5 KYORITSU SEIYAKU CORPORATION
    • TABLE 247 KYORITSU SEIYAKU CORPORATION: BUSINESS OVERVIEW
    • 11.2.6 SMARTVET HOLDINGS, INC.
    • TABLE 248 SMARTVET HOLDINGS, INC.: BUSINESS OVERVIEW
    • 11.2.7 UCBVET
    • TABLE 249 UCBVET: BUSINESS OVERVIEW
    • 11.2.8 CALIER
    • TABLE 250 CALIER: BUSINESS OVERVIEW
    • 11.2.9 ABBEY ANIMAL HEALTH PTY LTD.
    • TABLE 251 ABBEY ANIMAL HEALTH PTY LTD.: BUSINESS OVERVIEW
    • 11.2.10 BIOGENESIS BAGO
    • TABLE 252 BIOGENESIS BAGO: BUSINESS OVERVIEW
    • 11.2.11 PRN PHARMACAL
    • TABLE 253 PRN PHARMACAL: BUSINESS OVERVIEW
    • 11.2.12 LUTIM PHARMA PRIVATE LIMITED
    • TABLE 254 LUTIM PHARMA PRIVATE LIMITED: BUSINESS OVERVIEW
    • 11.2.13 VETANCO SA
    • TABLE 255 VETANCO SA: BUSINESS OVERVIEW
    • 11.2.14 BRILLIANT BIO PHARMA
    • TABLE 256 BRILLIANT BIO PHARMA: BUSINESS OVERVIEW
    • 11.2.15 ZUCHE PHARMACEUTICALS PVT. LTD.
    • TABLE 257 ZUCHE PHARMACEUTICALS PVT. LTD.: BUSINESS OVERVIEW
  • Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS